Actinium Pharmaceuticals (Delaware) (ATNM)'s 30-day implied volatility (IV30) was 72.7% at the close on October 22, 2026, down from 80.5% the day before, against a 52-week range of 42.7% to 260.0%. Its 20-day historical volatility was 87.1%.
Data as of October 22, 2026.